Objective: Inhaled nitric oxide (NO) is a selective pulmonary vasodila
tor, but its use has been restricted almost exclusively to the intensi
ve care setting due to the complexity of its delivery. NO/nucleophile
adducts, such as diethylenetriamine/NO (DETA/NO), spontaneously releas
e NO in aqueous solutions. We hypothesized that a nebulized DETA/NO (h
alf-time of NO release > 20 h) would stay in the lower airways and con
tinuously supply sufficient NO to achieve sustained vasodilation in ch
ronic pulmonary hypertension. Methods: Chronic pulmonary hypertension
was induced in rats by a monocrotaline injection, Nineteen days later,
nebulizations of DETA/NO were given on 4 consecutive days (5 and 50 m
u mol; 10 min/day). One day after the last nebulization, pulmonary and
systemic arterial pressure and cardiac output were measured after tho
racotomy. The lungs were isolated and perfused to study the pressure-f
low relationship. The effect of DETA/NO nebulization on acute vasocons
trictor reactivity was studied in additional isolated lungs. Results:
Total pulmonary, but not systemic, vascular resistance was significant
ly reduced by both DETA/NO doses, suggesting that DETA/NO, like NO, ca
uses preferential dilation of the pulmonary circulation. The pulmonary
perfusion pressure-flow curves were shifted downwards by DETA/NO trea
tment, indicating improved resistive properties of the pulmonary vascu
lature. DETA/NO nebulization into isolated lungs increased exhaled NO
levels and progressively reduced vasoconstrictor responses to angioten
sin II and acute hypoxia. These effects were not reversed by perfusate
exchange, In intact rats, carotid artery pressure and plasma NO2- + N
O3- levels did not change during and after DETA/NO nebulization. Concl
usion: DETA/NO nebulization offers a possibility of once a day, ambula
tory delivery of NO and is a potential treatment for chronic pulmonary
hypertension, although further studies are needed to establish safely
and selectivity.